Kjer's optic neuropathy
Kjer's optic neuropathy is a rare, inherited disorder that primarily affects the eyes, leading to vision loss. This condition is characterized by the onset of visual impairment in early childhood, which is typically severe by the second decade of life. Most affected individuals are legally blind by mid-adulthood. Despite severe vision loss, other eye-related symptoms are typically mild and most people with Kjer's optic neuropathy do not experience pain or discomfort in their eyes.
Signs and Symptoms
The primary symptom of Kjer's optic neuropathy is vision loss, which begins in early childhood. This vision loss is progressive, meaning it worsens over time. By the second decade of life, most individuals with this condition have severe vision loss. Despite this, other symptoms related to the eyes are typically mild. Most individuals do not experience pain or discomfort in their eyes.
Causes
Kjer's optic neuropathy is caused by mutations in the OPA1 gene. This gene provides instructions for making a protein that is found in cells throughout the body, including cells in the eye. The OPA1 protein is involved in maintaining the structure and function of mitochondria, which are the energy-producing centers within cells. Mutations in the OPA1 gene disrupt the function of the OPA1 protein, leading to the vision loss seen in Kjer's optic neuropathy.
Diagnosis
The diagnosis of Kjer's optic neuropathy is based on the presence of characteristic clinical features, including early-onset, progressive vision loss. Genetic testing can confirm the diagnosis by identifying a mutation in the OPA1 gene.
Treatment
There is currently no cure for Kjer's optic neuropathy. Treatment is focused on managing symptoms and improving quality of life. This may include the use of low-vision aids, such as magnifying glasses and large-print materials.
Prognosis
The prognosis for individuals with Kjer's optic neuropathy varies. Most individuals experience severe vision loss by the second decade of life and are legally blind by mid-adulthood. However, other eye-related symptoms are typically mild and most individuals do not experience pain or discomfort in their eyes.
See Also
| Mitochondrial diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
see also mitochondrial proteins
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


